|Buyback Dates||16/12/2019 - 30/12/2019|
|Buyback Offer||Rs.130.00 crores|
|Buyback Offer Size||3.68%|
|Number of Shares||29,54,545|
|Buyback Type||Tender Offer|
JB Chemicals and Pharmaceuticals Ltd. (JBCPL) is one of the fastest-growing pharma companies in India. The company established in 1976 headquartered in Mumbai. They are selling their products in India and International market. The company exports its products in 30 countries. They have over 1000 people working with the company. JB Chemicals NSE Code is JBCHEPHARM and BSE Code is 506943.
JB Chemicals buyback of 29,54,545 equity shares which is around 3.68% of all the existing number of equity shares at a price of ₹440 per equity share. The buyback offers not exceeding ₹130 crores of total buyback offer size.
The investors are eligible for the buyback scheme who have JB Chemicals shares in their Demat account as record date 22-Nov-2019. Investors can participate in the JB Chemicals Buyback 2019 scheme as per the opening form by selling your shares. The payment will be given as per the accepted shares by the company under the JB Chemicals buyback scheme.
Established in 1976, J.B.Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest growing pharmaceutical companies. An integrated, research-oriented, public listed organization with a focus on supplying affordable, quality products both in India and International markets, JBCPL is trusted by healthcare professionals globally. Today, JBCPL exports to over 30 countries across the world and earns more than half its revenue from its international business.
JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids, and capsules.
JBCPL has its headquarters in India’s financial capital, Mumbai. With a domestic sales force of 1,000 people, 17 internationally approved state of the art manufacturing units, a Research and Development Centre, and subsidiaries abroad, the organization is continually enhancing value for its shareholders.
In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL.
Board of Directors of the Company has, at its meeting held today inter-alia approved Buy-back of up to 29,54,545 fully paid-up Equity Shares of the face value of Rs. 2/- each by the Company (representing 3.68% of the total paid-up equity shares of the Company) at a price of Rs. 440/- (Rupees four hundred forty Only) per Equity Share payable in cash for a total consideration not exceeding Rs.130 crores/- (Rupees one hundred thirty Crores only) (excluding transaction costs) which is 9.33% and 9.38% of the total paid-up equity share capital and free reserves (including securities premium account) as per the audited standalone financial statements and audited consolidated financial statements of the Company for the financial year ended on March 31, 2019, respectively, through the "Tender Offer" route.
The Record Date for JB Chemicals Buyback is 22/11/2019.
The JB Chemicals Buyback will open on 16/12/2019 and closes on 30/12/2019.
The Buyback price of JB Chemicals is Rs.440.
The Buyback Type of JB Chemicals is Tender Offer.